To determine the specific transporter that could be regulated by mutated KRAS, we introduced two different small interfering RNAs (siRNAs) targeting KRAS in KRAS-mutant CRC cell lines (HCT116 and DLD-1). Here, KRAS is linked to colorectal carcinoma.